On April 26, Axinn partners Matt Becker and Aziz Burgy will speak at ACI’s Paragraph IV Disputes virtual conference.

Matt will speak on a panel entitled, "The Economics and Economy of Drug Patents with ACI’s Hatch-Waxman Series Advisory Board Members: Optimizing Product Selection, Identifying Targets for Litigation and Monetizing IP Portfolios." This breakout session will establish best practices for cost reduction to enhance predictability for cash flow purposes and evaluate the impact of the conservation of resources on future investment in research and development.

Aziz will speak on a panel entitled, "You Can’t Go Home Again…Or Can You? Establishing Venue in PIV Litigation Post-Valeant v. Mylan." This breakout session will help provide clarity as practitioners from both branded and generic drug companies revisit the present and anticipated state of the venue quandary.

Click here for more information, including how to register.